Amino-terminal Pro-B-Type natriuretic peptide among patients living with both human immunodeficiency virus and heart failure

Raza M. Alvi, Markella V. Zanni, Anne M. Neilan, Malek Z.O. Hassan, Noor Tariq, Lili Zhang, Maryam Afshar, Dahlia Banerji, Connor P. Mulligan, Adam Rokicki, Magid Awadalla, James L. Januzzi, Tomas G. Neilan

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Background. Among persons living with human immunodeficiency virus (PHIV), incident heart failure (HF) rates are increased and outcomes are worse; however, the role of amino-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations among PHIV with HF has not been characterized. Methods. Patients were derived from a registry of those hospitalized with HF at an academic center in a calender year. We compared the NT-proBNP concentrations and the changes in NT-proBNP levels between PHIV with HF and uninfected controls with HF. Results. Among 2578 patients with HF, there were 434 PHIV; 90% were prescribed antiretroviral therapy and 62% were virally suppressed. As compared to controls, PHIV had higher admission (3822 [IQR, 2413-7784] pg/ml vs 5546 [IQR, 3257-8792] pg/ml, respectively; P <.001), higher discharge (1922 [IQR, 1045-4652] pg/ml vs 3372 [IQR, 1553-5452] pg/ml, respectively; P <.001), and lower admission-to-discharge changes in NT-proBNP levels (32 vs 48%, respectively; P =.007). Similar findings were noted after stratifying based on left ventricular ejection fraction (LVEF). In a multivariate analysis, cocaine use, a lower LVEF, a higher NYHA class, a higher viral load (VL), and a lower CD4 count were associated with higher NT-proBNP concentrations. In follow-up, among PHIV, a higher admission NT-proBNP concentration was associated with increased cardiovascular mortality (first tertile, 11.5; second tertile, 20; third tertile, 44%; P <.001). Among PHIV, each doubling of NT-proBNP was associated with a 19% increased risk of death. However, among patients living without HIV, each doubling was associated with a 27% increased risk; this difference was attenuated among PHIV with lower VLs and higher CD4 counts. Conclusions. PHIV with HF had higher admission and discharge NT-proBNP levels, and less change in NT-proBNP concentrations. Among PHIV, VLs and CD4 counts were associated with NT-proBNP concentrations; in follow-up, higher NT-proBNP levels among PHIV were associated with cardiovascular mortality.

Original languageEnglish (US)
Pages (from-to)1306-1315
Number of pages10
JournalClinical Infectious Diseases
Volume71
Issue number5
DOIs
StatePublished - Sep 1 2020

Keywords

  • Amino-terminal pro-B-type natriuretic peptide
  • Cardiovascular mortality
  • Heart failure
  • Human immunodeficiency virus

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Amino-terminal Pro-B-Type natriuretic peptide among patients living with both human immunodeficiency virus and heart failure'. Together they form a unique fingerprint.

Cite this